HESTERBIO — Hester Biosciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapHigh Flyer

Annual balance sheet for Hester Biosciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	393	127	123	55.9	275
Net Total Accounts Receivable
Net Total Receivables	697	1,037	1,027	965	955
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	1,948	2,276	2,146	1,952	2,086
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	3,170	4,050	4,076	4,094	4,111
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	5,622	6,700	6,623	6,534	6,779
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	969	1,487	1,058	1,252	1,525
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	3,022	3,902	3,706	3,391	3,177
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	2,600	2,797	2,918	3,143	3,602
Total Liabilities & Shareholders' Equity	5,622	6,700	6,623	6,534	6,779
Total Common Shares Outstanding